home / stock / tsvt / tsvt articles

TSVT Articles, 2seventy bio Inc.

Stock Information
Company Name: 2seventy bio Inc.
Stock Symbol: TSVT
Market: NASDAQ
Website: 2seventybio.com
Menu
TSVT TSVT Quote TSVT Short TSVT News TSVT Articles TSVT Message Board
Get TSVT Alerts

News, Short Squeeze, Breakout and More Instantly...
Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma | Benzinga

On Thursday, 2seventy Bio Inc. (NASDAQ:TSVT) completed the asset purchase agreement with Novo Nordisk A/S (NYSE:NVO). Under the terms, Novo Nordisk...
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies | Benzinga

Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings??...

FDA Approves Bristol-Myers/2seventy Bio's Abecma For Earlier Use In Pretreated Blood Cancer Patients With Updated Boxed Warning On Secondary Cancer | Benzinga

Friday, the FDA approved Bristol-Myers Squibb Company (NYSE:BMY) and  2seventy Bio Inc’s (NASDAQ:TSVT) Abecma&n...

Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financ...
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer | Benzinga

Friday, the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted positively (8-3) favoring expanded use of Bristol Myers Squibb & C...

Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Nuvei Corp (NASDAQ: NVEI) rose sharply in today’s pre-market trading following a report indicating the company is in buyout talks ...

Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Cardlytics, Inc. (NASDAQ: CDLX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-...
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley | Benzinga

Morgan Stanley initiates Arcellx Inc (NASDAQ:ACLX), noting a differentiated CAR-T platform for blood cancer backed by an established...

Why Is Sanofi Partner Regeneron Pharmaceuticals Stock Trading Higher Today? | Benzinga

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported fourth-quarter adjusted EPS of $11.86, down 6% Y/Y, beating the consensus of $10.77....

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter ...
Next 10